000			01745na a2200229 4500
003			PC6716
005			20180417112618.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_9441 _aUrruzuno Tellería, Pedro _ePediatría
245	0	0	_aHelicobacter pylori in Pediatrics. _h[artículo]
260			_bHelicobacter, _c2013
300			_a18 Suppl 1:52-7.
500			_aFormato Vancouver: Alarcón T, José Martínez-Gómez M, Urruzuno P. Helicobacter pylori in pediatrics. Helicobacter. 2013 Sep;18 Suppl 1:52-7.
501			_aPMID: 24011246
504			_aContiene 51 referencias
520			_aThis review concerned the important pediatric studies published between April 2012 and March 2013. Symptomatology in Helicobacter pylori-positive children is nonspecific, except for those suffering from peptic ulcer diseases. Investigation of H.pylori status in children and adolescents with sideropenic anemia is recommended, and it is the aim of several studies worldwide. Associations of H.pylori with plasma ghrelin levels as well as the negative association of H.pylori with atopic disease were interesting objectives for several studies this year. Success rates of sequential therapy tended to be lower in recent studies than in previous trials, which probably reflects the increase in macrolide resistance. A beneficial effect of probiotics was reported although not all trials supported this result in children. Intrafamilial transmission and young age could be major risk factors associated with reinfection in children.
710			_9446 _aServicio de Pediatría-Neonatología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6716.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c6716 _d6716